While it may not sound like a major leap, this approach offers one big advantage: killing cancerous cells while doing less damage to surrounding healthy tissue.
The Phase 2 trial is conducted at Georgetown University Medical Center, Allegheny Health Network (AHN) Cancer Institute, UNC Medical Center, the UVA Cancer Center, John Theurer Cancer Center at ...